CLPTNCMHealthcare·Medical Devices#65 in industry

ClearPoint Neuro, Inc.

Reports in 8d· 2026-05-05

-22.1% · 90d

$11.21

-0.57 (-4.84%)

After-Hours $11.21(+0.00)

News

(2)

April 2026

Apr 23, 20264 days agoARSHealthcare

CLPT Annual Report Reviews Business Health, Strategy, and Financial Progress

CLPTClearPoint Neuro, Inc.

# 🧾 What This Document Is This is ClearPoint Neuro's **Annual Report to Shareholders (ARS)**. Think of it as the company's annual "State of the Union" address. It's a comprehensive review of their entire business from the past year, designed to give investors a complete picture of their health, st

Read summaryView on SEC EDGAR

Apr 10, 20262 weeks agoDEF 14AHealthcare

CLPT Annual Meeting to Vote on Directors and Stock Plan

CLPTClearPoint Neuro, Inc.

# 🧾 What This Document Is This is a **definitive proxy statement (DEF 14A)** for ClearPoint Neuro, Inc. It's the official invitation and information packet for the company's **2026 Annual Meeting of Stockholders**. The purpose is to give shareholders the details they need to vote on important compa

Read summaryView on SEC EDGAR

Key Data

Market Cap$336.1M

Open$11.60

Prev Close$11.78

Day Range$11.07 – $11.78

52W Range$8.27 – $30.10

Volume417,149

P/E (TTM)—

EPS$-0.90

Dividend Yield—

Beta1.18

Profit Margin-69.08%

Revenue Growth34.00%

Price Target$25.00(+123.0%)

Next Earnings2026-05-05(8d)

Analyst Ratings

Strong Buy2 analysts

Buy 2Hold 0Sell 0

About

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Healthcare · Medical Devices

172 employees

www.clearpointneuro.com